Can a smarter pacemaker lead protect the heart?

NCT ID NCT07759700

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether a newer pacing method, called left bundle branch area pacing, is better than the standard right ventricular pacing for adults with permanent atrial fibrillation and a need for a pacemaker. The goal is to see if the newer technique reduces the risk of death, heart failure hospitalizations, or the need for a more advanced pacemaker over two years. Participants are randomly assigned to receive one of the two pacing strategies and are followed with heart tests and quality-of-life questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Left bundle branch area pacing (a pacemaker lead placement technique) compared with conventional right ventricular pacing
What this could lead to
If left bundle branch area pacing proves better, it could become the preferred pacing method for people with atrial fibrillation, reducing heart failure risk and improving quality of life.
What could go wrong
This is a randomized trial, but the outcome depends on long-term follow-up. The new pacing technique may not reduce complications or could have unforeseen risks compared with standard pacing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERMANENT ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.